REGENXBIO Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Accelerated filer
Business Address 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Mailing Address 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Phone 240-552-8181
Fiscal Year End 1231
EIN 471851754
Financial Overview
FY2024
-$227.10M
Net Income
$573.97M
Total Assets
$262.23M
Total Liabilities
$96.95M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 424B5 Prospectus supplement | February 12, 2026 | View on SEC |
| 8-K Current report of material events | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 28, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
Material Events
8-K Other February 10, 2026
High Impact
- REGENXBIO is committed to finding a path forward for RGX-121 despite the setback.
- The company has approximately $400 million in cash and equivalents, providing some financial runway.
8-K Other January 28, 2026
High Impact
- Targeting severe, rare genetic disorders (MPS I and MPS II) with desperately needed treatments.
- RGX-111 and RGX-121 are crucial assets in its pipeline.
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.